$CLOV News

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $5.5

Clover Health says employee accounts accessed in cyber incident

Clover Health Investments Reports Anomalous Login Activity On Information Systems On July 4, 2026; Does Not Expect Material Impact From Incident; Threat Actor Accessed Three Non-Managerial Employee Accounts Via Social Engineering; Accessed Accounts Had Member Data But No Access To Financial Or Claims Systems; Co. Believes Unauthorized Access Was Contained And Terminated

Clover Health Investments (CLOV) Faces A Valuation Test Ahead Of August Earnings

Is Clover Health Investments (CLOV) Reasonable After Its 3.8x Run?

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.

UBS Nearly Doubles Its Price Target on Clover Health (CLOV)

Spotting Winners: Clover Health (NASDAQ:CLOV) And Health Insurance Providers Stocks In Q1

A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.

Clover Health (CLOV): 3 Reasons We Love This Stock

Clover Health Investments' Clover Care Services CEO Brady Priest Stepping Down; Co. Integrating Its Home-Care Business With Its Broader Operations; Not Appointing Priest's Successor

UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75

Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating

Clover Health (CLOV)Hits Fresh Peak on Unexpected CMS Rating

A Court Order Sent CLOV Stock To Over 4.5-Year Highs – Retail Says The Implications Could Be Industry-Wide

Clover Health Announces That Its 2026 Star Rating Has Been Recalculated At 4.5 Following U.S. Court's Summary Judgement

A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors?